Qiagen NV at JPMorgan Healthcare Conference Transcript
All right. Great. Thank you, everybody, for joining us today. I'm Casey Woodring from the Life Science Tools and Diagnostics team here at JPMorgan. Welcome to our conference. Here with me today, we have QIAGEN's, CEO, Thierry Bernard, following Thierry's presentation, we'll have a short Q&A session. But for now, I'll just turn it over to Thierry. Thierry?
Thank you so much, Casey, and good morning to everybody. I suggest that we are going to wait just a couple of seconds to have everybody getting in. Okay. I think we at -- I think we can start now. So welcome again. Thanks for your interest in QIAGEN. And obviously, in January, a very happy New Year to you all, to your companies. It's a pleasure to be with you again after -- last time I presented here at JPM was in January of 2020. So clearly, 2 years after, I think it's a pleasure to be presential and not only virtual.
And I'd like to spend the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
